The rise of Viagra initially fueled a surge for pharma, but recent developments present a uncertain scenario for shareholders. Generic versions are eroding profits, and continued patent challenges add further https://murrayssge545957.ltfblog.com/39645814/sildenafil-and-pharma-a-precarious-bet